Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CASC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00674 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
R3HDM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPO5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4EBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRELID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ARHGEF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on